Medicare urged to lower insurance hurdles amid shortage of repackaged Avastin; UnitedHealth’s profit jumps as medical costs come in lower than expected

Taking stock of the drug industry, from the lab to the medicine chest

October 13, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Eye docs urge Medicare to lower insurance hurdles amid shortage of repackaged Avastin The largest supplier of repackaged Avastin began a recall this month after the FDA inspected its facilities and found sterility issues By Ed Silverman STAT+ | UnitedHealth's profit jumps as medical costs come in lower than expected Even though more people are getting medical care this year, that is certainly not dragging down the UnitedHealth Group's profits. By Bob Herman STAT+ | HHS dispatches millions to next-generation Covid targets, including intranasal vaccine HHS invests in 13 projects, including development of intranasal Covid vaccines, monoclonal antibodies, and "self-amplifying mRNA." By Sarah Owermohle Illustration: Alex Hogan/STAT; Photo: Eisai via AP STAT+ | Medicare to cover more brain scans related to Alzheimer's drugs Previously, Medicare limited coverage for the drug to patients enrolled in Alzheimer's trials, and only covered one scan in a lifetime. By Rachel Cohrs STAT+ | Amgen reports first clinical data on new targeted cancer therapy The company's preliminary results showed five partial responses from 31 evaluable patients who received the treatment. By Adam Feuerstein

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser